AR vaccine (Madison Vaccines)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameAR vaccine (Madison Vaccines)
Drug Alias NamepTVG-ARMVI-118
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulantsAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMadison Vaccines Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesMadison Vaccines Inc
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A